Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SERPINH1 | P50454 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5405677 | 0.93 | ALDH1A1 (0.58) | ALDH1A1CYP2C19LMNATSHRSERPINH1 | |
| SCHEMBL14338543 | 0.87 | ALDH1A1 (0.67) | ALDH1A1CYP2C19LMNAL3MBTL1MAPT | |
| SCHEMBL14338545 | 0.87 | ALDH1A1 (0.67) | ALDH1A1CYP2C19LMNAL3MBTL1MAPT | |
| SCHEMBL14338542 | 0.86 | ALDH1A1 (0.66) | ALDH1A1CYP2C19LMNAMAPTMEN1 | |
| SCHEMBL14338541 | 0.86 | ALDH1A1 (0.66) | ALDH1A1CYP2C19LMNAL3MBTL1MAPT | |
| SCHEMBL14338544 | 0.86 | ALDH1A1 (0.70) | ALDH1A1CYP2C19LMNASERPINH1L3MBTL1 | |
| SCHEMBL18106496 | 0.86 | ALDH1A1 (0.70) | ALDH1A1CYP2C19LMNASERPINH1L3MBTL1 | |
| SCHEMBL18106707 | 0.86 | ALDH1A1 (0.70) | ALDH1A1CYP2C19LMNASERPINH1L3MBTL1 | |
| SCHEMBL29434418 | 0.86 | ALDH1A1 (0.70) | ALDH1A1CYP2C19LMNASERPINH1L3MBTL1 | |
| SCHEMBL16785484 | 0.85 | ALDH1A1 (0.65) | ALDH1A1CYP2C19LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114369090-A | Mesoionic compound and preparation method and application thereof | 东莞市东阳光农药研发有限公司 | 2022-04-19 | — | — | CN | disclosed |
| US-7332622-B2 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGUKU KABUSHIKI KAISHA (JP) | 2008-02-19 | — | — | US | disclosed |
| US-7312335-B2 | Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts | BRANDEIS UNIVERSITY (US) | 2007-12-25 | — | — | US | disclosed |
| US-7312335-B2 | Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts | BRANDEIS UNIVERSITY (US) | 2007-12-25 | — | — | US | disclosed |
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2005-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101787-A1 | Process for preparing optically active nitro compounds and cyano compounds | NOS1, NOS2, NOX1 | ALDH1A1 1008/4885CYP2C19 98/4885LMNA 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.